Get the app
US › Healthcare

Aethlon Medical Inc (AEMD)

US · Healthcare · Medical Devices

$5.47+3.01%
Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Net profit
$-1.5M
EPS
$-4.02
EPS estimate
$-4.05

EPS came in at -4.02 against a street estimate of -4.05 — a beat of 0.7%.

Key statistics

Market cap
$8.5M
Forward P/E
0.2
P/B
0.79
Book value
$10.89
EPS (TTM)
$-30.88
52-week high
$25.66
52-week low
$1.41
50-day MA
$4.65
200-day MA
$7.65
Beta
1.23

Analyst view

Analysts rate Aethlon Medical Inc a hold (0 buy, 2 hold, 0 sell out of 2) with an average price target of $13.25.

Shareholding

Insiders
3.13%
Institutions
6.99%

Largest institutional holders

FundStake
HRT FINANCIAL LLC2.05%
Shay Capital LLC0.87%
Ikarian Capital, LLC0.40%
Geode Capital Management, LLC0.29%
Scientech Research LLC0.28%
UBS Group AG0.25%
Tower Research Capital LLC0.18%
Morgan Stanley - Brokerage Accounts0.07%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Aethlon Medical Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.